» Articles » PMID: 36307832

Transcriptome Analysis of Sputum Cells Reveals Two Distinct Molecular Phenotypes of "asthma and Chronic Obstructive Pulmonary Disease Overlap" in the Elderly

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2022 Oct 29
PMID 36307832
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Little is known about the pathogenesis of asthma and chronic obstructive pulmonary disease (COPD) overlap (ACO). This study examined the molecular phenotypes of ACO in the elderly.

Methods: A genome-wide investigation of gene expression in sputum cells from the elderly with asthma, ACO, or COPD was performed using gene set variation analysis (GSVA) with predefined asthma- or COPD-specific gene signatures. We then performed a subsequent cluster analysis using enrichment scores (ESs) to identify molecular clusters in the elderly with ACO. Finally, a second GSVA was conducted with curated gene signatures to gain insight into the pathogenesis of ACO associated with the identified molecular clusters.

Results: Seventy elderly individuals were enrolled (17 with asthma, 41 with ACO, and 12 with COPD). Two distinct molecular clusters of ACO were identified. Clinically, ACO cluster 1 (N = 23) was characterized by male and smoker dominance, more obstructive lung function, and higher proportions of both neutrophil and eosinophil in induced sputum compared to ACO cluster 2 (N = 18). ACO cluster 1 had molecular features similar to both asthma and COPD, with mitochondria and peroxisome dysfunction as important mechanisms in the pathogenesis of these diseases. The molecular features of ACO cluster 2 differed from those of asthma and COPD, with enhanced innate immune reactions to microorganisms identified as being important in the pathogenesis of this form of ACO.

Conclusion: Recognition of the unique biological pathways associated with the two distinct molecular phenotypes of ACO will deepen our understanding of ACO in the elderly.

Citing Articles

Severity of Lung Function Impairment Drives Transcriptional Phenotypes of COPD and Relates to Immune and Metabolic Processes.

Negewo N, Gibson P, Simpson J, McDonald V, Baines K Int J Chron Obstruct Pulmon Dis. 2023; 18:273-287.

PMID: 36942279 PMC: 10024507. DOI: 10.2147/COPD.S388297.

References
1.
Brandsma C, de Vries M, Costa R, Woldhuis R, Konigshoff M, Timens W . Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?. Eur Respir Rev. 2017; 26(146). PMC: 9488745. DOI: 10.1183/16000617.0073-2017. View

2.
Royce S, Cheng V, Samuel C, Tang M . The regulation of fibrosis in airway remodeling in asthma. Mol Cell Endocrinol. 2012; 351(2):167-75. DOI: 10.1016/j.mce.2012.01.007. View

3.
Bhakta N, Solberg O, Nguyen C, Nguyen C, Arron J, Fahy J . A qPCR-based metric of Th2 airway inflammation in asthma. Clin Transl Allergy. 2013; 3(1):24. PMC: 3724712. DOI: 10.1186/2045-7022-3-24. View

4.
Graham L, Brown G . The Dectin-2 family of C-type lectins in immunity and homeostasis. Cytokine. 2009; 48(1-2):148-55. PMC: 2756403. DOI: 10.1016/j.cyto.2009.07.010. View

5.
Zeki A, Schivo M, Chan A, Albertson T, Louie S . The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly. J Allergy (Cairo). 2011; 2011:861926. PMC: 3205664. DOI: 10.1155/2011/861926. View